NASDAQ

Protagonist Therapeutics, Inc. (PTGX)

♥ 574 Thanks from members

Live price chart, market sentiment, and community perspectives for Protagonist Therapeutics, Inc. (NASDAQ: PTGX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Jacob Bau (Scientific Founder)Leadership: Dinesh V. Patel (President and CEO)Leadership: Suwak Ghosh (CFO)Holder: Baker Bros. AdvisorsHolder: Vanguard Group, Inc.Holder: FMR LLCJNJ-2113 (Rusfertide)Oral Peptide TherapeuticsHematology Pipelines#PTGX#Protagonist Therapeutics#Biotech Stock#Nasdaq PTGX#Peptide Therapeutics